8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 21, 2023 · 3y ago · Accession 0001193125-23-171257
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Atea Pharmaceuticals, Inc.
- Ticker
- AVIR
- CIK
- 1593899
- Form type
- 8-K
- Filing date
- Jun 21, 2023
- Report date
- Jun 16, 2023
- Document
- d467534d8k.htm
- Size
- 677 KB